Andreas Polychronis

2.3k total citations · 1 hit paper
33 papers, 1.1k citations indexed

About

Andreas Polychronis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and General Health Professions. According to data from OpenAlex, Andreas Polychronis has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in General Health Professions. Recurrent topics in Andreas Polychronis's work include Primary Care and Health Outcomes (6 papers), Occupational and environmental lung diseases (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Andreas Polychronis is often cited by papers focused on Primary Care and Health Outcomes (6 papers), Occupational and environmental lung diseases (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Andreas Polychronis collaborates with scholars based in United Kingdom, United States and Italy. Andreas Polychronis's co-authors include Joseph E Grey, A. Miles, R. Charles Coombes, P. Bentley, Nicholas C. Price, Marcis Bajars, Mary Ruisi, Mustafa Özgüroğlu, Fabrice Barlési and Hidenobu Ishii and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and European Journal of Cancer.

In The Last Decade

Andreas Polychronis

27 papers receiving 1.1k citations

Hit Papers

Avelumab versus docetaxel in patients with platinum-treat... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study
    2018 336 citations Fabrice Barlési, Johan Vansteenkiste et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Polychronis United Kingdom 13 613 339 280 182 126 33 1.1k
Praveen Vikas United States 13 551 0.9× 139 0.4× 263 0.9× 71 0.4× 158 1.3× 27 988
Jill Kolesar United States 19 329 0.5× 139 0.4× 296 1.1× 72 0.4× 146 1.2× 68 948
Teresita Muñoz-Antonia United States 17 375 0.6× 149 0.4× 631 2.3× 51 0.3× 165 1.3× 49 1.0k
Chiledum Ahaghotu United States 21 265 0.4× 406 1.2× 330 1.2× 92 0.5× 151 1.2× 39 1.2k
Pilar Zamora Spain 17 303 0.5× 195 0.6× 270 1.0× 37 0.2× 202 1.6× 55 795
Elizabeth R. Kessler United States 17 391 0.6× 571 1.7× 462 1.6× 58 0.3× 219 1.7× 87 1.2k
Amy Tiersten United States 20 1.0k 1.7× 324 1.0× 264 0.9× 34 0.2× 275 2.2× 101 1.6k
Paulo Gustavo Bergerot United States 16 515 0.8× 445 1.3× 373 1.3× 39 0.2× 209 1.7× 94 980
Friedrich Overkamp Germany 13 356 0.6× 204 0.6× 149 0.5× 48 0.3× 206 1.6× 64 592
Mehmet Akif Öztürk Türkiye 12 295 0.5× 147 0.4× 151 0.5× 89 0.5× 128 1.0× 40 642

Countries citing papers authored by Andreas Polychronis

Since Specialization
Citations

This map shows the geographic impact of Andreas Polychronis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Polychronis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Polychronis more than expected).

Fields of papers citing papers by Andreas Polychronis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Polychronis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Polychronis. The network helps show where Andreas Polychronis may publish in the future.

Co-authorship network of co-authors of Andreas Polychronis

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Polychronis. A scholar is included among the top collaborators of Andreas Polychronis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Polychronis. Andreas Polychronis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Polychronis, Andreas, et al.. (2024). Advantages and Disadvantages of Reconstructive and Preservation Rhinoplasty: Surgical Techniques, Outcomes, and Future Directions. Cureus. 16(9). e69002–e69002. 1 indexed citations
2.
3.
Polychronis, Andreas, et al.. (2024). A Comparative Analysis of the Advances in Scar Reduction: Techniques, Technologies, and Efficacy in Plastic Surgery. Cureus. 16(8). e66806–e66806. 2 indexed citations
4.
5.
Polychronis, Andreas, Γεώργιος Αντωνίου, Arshi Denton, et al.. (2024). 85 Assessing tolerability and toxicity of adjuvant Osimertinib following tumour resection of early-stage EGFR-mutated non-small cell lung cancer through real-world data. Lung Cancer. 190. 107646–107646.
6.
Afxentiou, Thalia, Andreas Polychronis, Arshi Denton, et al.. (2024). 63 Real-world outcomes of Nivlolumab-Ipilimumab combination therapy in unresectable malignant mesothelioma: Mount Vernon Cancer Centre Experience. Lung Cancer. 190. 107624–107624.
7.
Park, Keunchil, Mustafa Özgüroğlu, Johan Vansteenkiste, et al.. (2021). Avelumab Versus Docetaxel in Patients With Platinum-Treated Advanced NSCLC: 2-Year Follow-Up From the JAVELIN Lung 200 Phase 3 Trial. Journal of Thoracic Oncology. 16(8). 1369–1378. 40 indexed citations
8.
Katopodis, Periklis, Julie Davies, Harpal Randeva, et al.. (2021). COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease. International Journal of Molecular Medicine. 47(4). 23 indexed citations
9.
Sharma, Anand, et al.. (2013). Squamous cell carcinoma of pancreas: an unusual site of relapse from early-stage lung cancer: 12-month postsurgery. BMJ Case Reports. 2013. bcr2013009096–bcr2013009096. 3 indexed citations
10.
McGovern, Ursula, Richard E. Francis, Barrie Peck, et al.. (2009). Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer. Molecular Cancer Therapeutics. 8(3). 582–591. 115 indexed citations
11.
Miles, Andrew, Michael Loughlin, & Andreas Polychronis. (2007). Medicine and evidence: knowledge and action in clinical practice. Journal of Evaluation in Clinical Practice. 13(4). 481–503. 47 indexed citations
12.
13.
14.
Miles, A., et al.. (2004). Developments in the evidence‐based health care debate – 2004. Journal of Evaluation in Clinical Practice. 10(2). 129–142. 33 indexed citations
15.
Miles, A., et al.. (2003). Current thinking in the evidence‐based health care debate. Journal of Evaluation in Clinical Practice. 9(2). 95–109. 44 indexed citations
16.
Miles, A., P. Bentley, Andreas Polychronis, & Joseph E Grey. (1997). Evidence‐based medicine: why all the fuss? This is why. Journal of Evaluation in Clinical Practice. 3(2). 83–86. 68 indexed citations
17.
Miles, Andrew, Declan O'Neill, & Andreas Polychronis. (1996). Central dimensions of clinical practice evaluation: efficiency, appropriateness and effectiveness ‐ II. Journal of Evaluation in Clinical Practice. 2(2). 131–152. 3 indexed citations
18.
Miles, Andrew, et al.. (1996). The Total Health Care Audit System: a systematic methodology for clinical practice evaluation and development in NHS provider organizations. Journal of Evaluation in Clinical Practice. 2(1). 37–64. 7 indexed citations
19.
Miles, A., P. Bentley, Andreas Polychronis, Nicholas C. Price, & Joseph E Grey. (1996). Clinical audit in the National Health Service: fact or fiction?. Journal of Evaluation in Clinical Practice. 2(1). 29–35. 24 indexed citations
20.
Miles, A., P. Bentley, Joseph E Grey, & Andreas Polychronis. (1995). Purchasing quality in clinical practice: what on Earth do we mean?. Journal of Evaluation in Clinical Practice. 1(2). 87–95. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Praveen Vikas Breakdown of academic impact, for papers by Jill Kolesar Breakdown of academic impact, for papers by Teresita Muñoz-Antonia Breakdown of academic impact, for papers by Chiledum Ahaghotu Breakdown of academic impact, for papers by Pilar Zamora Breakdown of academic impact, for papers by Elizabeth R. Kessler Breakdown of academic impact, for papers by Amy Tiersten Breakdown of academic impact, for papers by Paulo Gustavo Bergerot Breakdown of academic impact, for papers by Friedrich Overkamp Breakdown of academic impact, for papers by Mehmet Akif Öztürk
Rankless by CCL
2026